4312-09-8 Usage
Description
(5E)-5-(phenylhydrazono)quinolin-8(5H)-one is a chemical compound with the molecular formula C16H11N3O. It is a derivative of quinolin-8-one, which is a heterocyclic compound with a quinoline backbone. The presence of the phenylhydrazono group gives this compound its characteristic properties. It may have potential applications in various fields due to its unique structure and reactivity.
Uses
Used in Organic Synthesis:
(5E)-5-(phenylhydrazono)quinolin-8(5H)-one is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure and reactivity make it a valuable building block in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
(5E)-5-(phenylhydrazono)quinolin-8(5H)-one is used as a potential drug candidate for the development of new therapeutic agents. Its unique structure and reactivity may contribute to the discovery of novel pharmaceuticals with improved efficacy and selectivity.
Used in Material Science:
(5E)-5-(phenylhydrazono)quinolin-8(5H)-one is used as a component in the development of new materials with specific properties. Its unique structure and reactivity may enable the creation of advanced materials with applications in various industries.
Further research and testing are necessary to fully understand the potential uses and properties of (5E)-5-(phenylhydrazono)quinolin-8(5H)-one. Its unique structure and reactivity may unlock new opportunities in various fields, making it an exciting compound for future studies.
Check Digit Verification of cas no
The CAS Registry Mumber 4312-09-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,1 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4312-09:
(6*4)+(5*3)+(4*1)+(3*2)+(2*0)+(1*9)=58
58 % 10 = 8
So 4312-09-8 is a valid CAS Registry Number.
4312-09-8Relevant articles and documents
Cobalt(II) complexes with pyridine and 5-[(E)-2-(aryl)-1-diazenyl]-quinolin-8-olates: synthesis, electrochemistry and X-ray structural characterization
Basu Baul, Tushar S.,Nongsiej, Khrawborlang,Rocha, Bruno G. M.,Guedes da Silva, M. Fátima C.
, p. 2856 - 2874 (2018)
Nine new cobalt(II) compounds, trans-[Co(LPAQ)2(Py)2] (1), trans-[Co(LPAQ)2(3-MePy)2] (2), trans-[Co(LMeAQ)2(Py)2] (3), trans-[Co(LOMeAQ)2/
Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents
Al-Oudat, Buthina A.,Al-Shar'i, Nizar A.,Bedi, Mel F.,Bryant-Friedrich, Amanda,Jaradat, Hana'a M.,Al?Balas, Qosay A.
, (2020/07/10)
The enzyme glyoxalase-I (Glo-I) is an essential therapeutic target in cancer treatment. Significant efforts have been made to discover competitive inhibitors of Glo-I as potential anticancer agents. Herein, we report the synthesis of a series of diazenylb
Supramolecular structures and stereochemical versatility of azoquinoline containing novel rare earth metal complexes
El-Sonbati,Issa,El-Gawad, A.M. Abd
, p. 134 - 138 (2008/02/13)
Rare earth complexes of 5-(phenylazo)-8-hydroxyquinoline (HL) of composition [M(L)2X·H2O] [where M = La, Ce, Pr, Nd and X = NO3- or NCS-] have been prepared and characterized on the basis of their che
